Premium
Letter: the addition of an immunosuppressant in patients with unsatisfactory response to vedolizumab
Author(s) -
Macaluso F. S.,
Orlando R.,
Renna S.,
Sapienza C.,
Ventimiglia M.,
Rizzuto G.,
Cottone M.,
Orlando A.
Publication year - 2018
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.14541
Subject(s) - vedolizumab , medicine , ulcerative colitis , disease